It really gives me great pleasure to introduce today's speaker, Dr. Frank Rizzullo. He's an associate professor of anesthesiology and intensive care at University Hospital in Russia, Italy, where he has the neurocritical care department. And he's also the director of the residency program for anesthesia and intensive care. He's also the chair of neuroanesthesia and neurocritical care section of the Italian Society of Anesthesia and Intensive Care. And his research focus has been on intracranial pressure, which is anything to chat to us about today, on which he has published a new rule articles. One of his most recent articles published in Critical Care was the IMPRESIT-2 trial, which is a principal investigator. And this was a prospective multicenter international trial that looked at transcranial Doppler as a screening tool to exclude intracranial hypertension in patients who present with brain injury. So I know our neurocritical care group is super thrilled.
to have him here so please join me in welcoming him here today with us. Thank you, Melissa, for the wonderful introduction. And it's a pleasure and honor to speak for you all. And I usually start when they invite me abroad in Italy, especially in England. I usually start by saying, excuse my English. I don't speak English because I'm from New Jersey, but I kind of feel at home here. So this is my hospital. It's in Brescia. It's up north. And these are my disclosures. None for this talk. This is where I'm speaking from at the moment. Unfortunately, my hospital has kind of a sad record for being the largest COVID-19 hospital in the world.
after Wuhan, because we were the first to have been involved by COVID-19 after the outbreak in China. And we were hit kind of hard. At one point, we had more than 1,000 COVID-19 patients admitted to our hospital. Anyway, we're here for the intracranial hypertension talk. So just by giving you a very quick definition, as I asked Melissa, I didn't know who the audience was composed of. So I'll start from very basics and excuse me for being oversimplistic sometimes, and then I'll move towards something a bit more up to date. So defined as a sustained elevation of intracranial pressure above normal threshold values. What is the normal threshold value? Well, it kind of depends on type of pathology and on the position a person may be.
whether you're lying down or standing up, and also body composition. We know that obesity is kind of correlated with a higher threshold of intracranial pressure. So let's say above 1520, you're still within a normal ICP threshold. I would say that intracranial hypertension obviously is not something new since there are indications of people being trepanated, drill hold, dating back to almost 2,000 years before Christ. The ancient Egyptians have done it. And through the years until the Inca also have done it. And actually they've done quite a good job, as you can see on the right. This is a gold plate which has been positioned beneath the patient's scalp. And the patient actually survived since you can see the healing of that skull itself.
And through the years until the 16th century, they kind of performed it a bit more eventually. But you can see here the surgeon was performing this trefonation with his tool. And he kind of looked pretty mad here, as you can tell by his face. And in a very difficult, obviously, non-antiseptic situation, you have here the cat, which was eating God knows what, and the terrible tools here also. Things kind of changed through the 18th century already by, you can tell, the face of the surgeon here, which is kind of, let's say, pretty satisfied for what job he was doing. And also his position of his hands with his pinkies are raised as if he was drinking tea at the time. Patient's face hasn't changed much, but the velvet container of the utensils has also.
So let's get into the argument a bit deeper. It wasn't until Monroe first described a certain doctrine, which is now called the Monroe Kelly doctrine. I know you're all familiar with it. And basically what it says that the brain is contained within a rigid container, which is a skull. And the brain is roughly composed of three main components, brain, blood, and CSF, a cerebral spinal fluid. Brain mostly 80%, blood composes 10%, and CSF another 10%.
If one or more of these components should increase, then at least one or two of the other components should decrease in order to maintain a constant volume and therefore constant pressure within this rigid container, which is our skull. Almost as if you can imagine somebody walking into a completely full elevator. If one or two people need to get into that elevator, then they would have to be substituted with another two people, one or two people moving out, or else the elevator would have to increase in diameter, which is obviously not possible. So that kind of brings us to the definition of compliance. Now, we know the brain is compliant. If these mechanisms are maintained, then we could imagine, as drawn here, that if a mass would increase within the brain, in this case, it's a epidural hematoma, then the mechanisms which would normally compensate, which I've shown you in previous slides, they would compensate until a certain point where large increases of volume would only represent small increases in ICP. Once these mechanisms have been
you can say it terminated, then there's no more compensation. Therefore, small increases of intracranial volume would represent large increases in intracranial pressure due to the exhausted, that's the word I was trying to find, exhausted mechanisms. So you would have initially high compliance due to the Monroe Kelly doctrine, then the compliance would start to decrease, and then they would become minimal until a point where the vessels would collapse because of an imploding high intracranial pressure within the cranium, which would exert its pressure internally, since it's not possible to exert it externally.
Now, this is just an example of how this compliance can change. If I were to ask you if this is a normal CT scan, obviously you're all experts. It looks like a very tight brain, but it's actually a normal CT scan of a 12-year-old. Now, this 12-year-old, although the 12-year-old, obviously normal 12-year-old, would have normal compensatory mechanisms, still the brain being a bit tight, you would have an initial phase of compensation, and then that would move to the exhaustion of the mechanisms which normally compensate until you have exhaustion of the PDI index. Is this a normal brain? Well, this is a brain atrophy due to chronic abuse of alcohol going from 2008 to 2014. My brain would probably be the version of 2023. Anyway, you can see that here there's a lot. You can imagine that this brain has a lot of space due to brain atrophy, and therefore the compliance would be greater. And that's actually the case. If we were to...
exert pressure due to maybe if this patient were to have a subdural hematoma, which is quite common in these patients, subdural hematoma, that would cause a problem only when the intracranial, only when the volume would surpass a certain volume, definitely larger than the previous patient, and only then will the intracranial pressure start to increase. And this is well documented in many papers, that older patients may have higher GCS scores despite equal TDI severity because of the compensatory mechanisms. However, these patients, although they do have higher GCS scores, they have a higher mortality because older patients, elderly patients do use, they're fragile, so they do have a tendency to use anti-platelet drugs or anti-coagulants, so they say the mortality is higher. This is a very recent patient that we had in the intensive care unit. This patient came in awake, it's say intraperinectal hematoma. Patient had a GCS of maybe 14, 68-year-old patient, and the neurosurgeons, both because of the
high GCS, and because of the fact there was an intracranial hematoma in a patient, 68-year-old, they decided not to operate the patient. So we performed a few CT scans, and they all showed increase in the hematoma. And it was only until the patient had this sign, I call it the ghost sign, because it does look like a ghost within the brain, did the patient have a rapid deterioration in the cognitive. The patient did have a rapid cognitive decline, and therefore, obviously, went off to having an unfortunate outcome. So what are the main causes of intracranial hypertension? They can be classified into intracranial causes or extracranial causes. I won't get into them specifically. Let's just mention that among the extracranial causes, you can have an important increase in intracranial pressure, which can determine outcome in a patient, for example, with acute liver failure. Many patients die because of the intracranial hypertension before liver failure itself. So it is a problem among many types of pathologies. And there are chronic forms of intracranial hypertension.
as we know that anything which is formed chronically may exert lesser clinical problems on patients. In this case, intracranial idiopathic hypertension, since it does increase maybe through the years, may not have clinical significance until some certain mechanisms of compensation also here are exhausted. For example, maybe due to a difference in the ratio of CSF production and drainage, and these are all the causes here. I may also leave you slides if you're interested, so you could look at these later on. Regarding, I will speak mostly about TVI because I think also in your region, in the Baltimore region, we have high incidence of TVI since we do have also here for various reasons, whether it be falls or violence inflicted or even.
traffic accident causes. And regarding TBI itself, you can have increases of higher risk of having an intracranial hypertension based on a type of TBI, whether it be parenchymal lesions and contusions do have the higher risk of having intracranial hypertension. They are associated with a higher mortality. If you have a vascular lesion, then the subdural hematomas are the ones that are highly prone to have an increase in ICP and therefore intracranial hypertension and therefore increase in mortality. So therefore, injury...
uh brain injury is associated with a uh commonly with a higher incidence of intrapreneur hypertension because of the mechanisms which i've spoken to previously about previously and i kind of look at it as if we were dealing with a pressure cooker now if the mechanisms work then the pressure cooker valve um is working and kind of set lets off the steam and keeps that pressure constant if this mechanism until the pressure in the pressure cooker would increase to a point where that valve would not be enough to um let out the steam and therefore the pressure would increase and this would cause a problem within cerebral circulation causing the vessels to implode and eventually to surpass the critical closing pressure and this would cause a reduction of cerebral blood flow until reaching cerebral circulatory arrest in certain cases. Therefore, we know that cerebral blood flow is conditioned by cerebral perfusion pressure, which is the driving pressure of bringing blood within the brain. And that is a cerebral perfusion pressure we know is the difference between mean arterial pressure and ICP itself. So if we have an increase in ICP, cerebral blood flow will reduce unless we increase mean arterial blood pressure. And that will kind of compensate and bring CBF back to normal values. And vice versa, if we were to reduce blood flow, mean arterial blood flow, that would cause a reduction in cerebral blood flow unless we reduce ICP. So there is...
a cerebral auditory mechanism here involved, which we'll speak about later on. So what about outcome? We know injury is associated to increases in ICP, and intricate hypertension is associated to a poor outcome in brain injury patients. We have no doubt about this, and this has been known ever since the early studies have been performed by Narayan and Marmaru. a few years back where they've seen that within the studies performed that 20 a threshold of 20 millimeters hg based on the outcome of these experimental studies and studies on patients regarding patients did represent a threshold above which we would consider it to be uh intracranial hypertension based on the outcome of patients and this has been uh adapted within the brain travel foundation guidelines first published in 1995 where they where they considered intracranial hypertension as a pressure above 20 millimeters hg It remains so until the third edition of the Brain Trial Foundation guidelines, until we reach the fourth edition published in 2012, where just one single study published by Sorrentino, I believe in the Cambridge group, it was a retrospective study in 459 patients, where they took into consideration also the cerebral reactivity.
of the autoregulation. And based on this single study, they increased the threshold to 22 millimeters HG. So that's just two millimeters HG. Does this make a significant difference on the outcome of these patients? Well, possibly not, but that's what the present threshold is. Another important concept is the dose of the intensity. Now, if we were to compare the intensity of intracranial pressure to, let's say, to heat. Now, if we expose somebody,
to a sun, especially somebody with a fair skin, for a very long period of time without any sun protectors, then eventually this person will have a lesion due to the sun rays, which is not a high intensity, but because of the long exposure, the patient will have, the person, sorry, will have a consequence. However, if somebody were to walk on charcoal or on very heated charcoal, Even though the stimulation is of high intensity, but the time that the skin is on top of the on the.
the coal and the charcoal is such a short period of time, this person here will most likely not have any lesions. So it doesn't only depend on the intensity itself, but also of the exposure, but also on the duration. And this has been studied quite well by the group in Belgium, where they've seen, as you see in red, you would have the patients who had a poor outcome, in blue, a good outcome. And you can see on the bottom here, you would have the intensity. And so...
If you would have an intensity, and therefore, an intracranial pressure of 25 millimeters hg, on the left, you would have the duration of the insult. In this case, at 25, you would have important insults. You would have a modification of the outcome towards a poor outcome, even at a few minutes. On the other hand, if someone were to have 15 minutes of intracranial pressure, as we all do, then the outcome will, you would not have any consequences of outcome unless the patient is a TBI patient, or as in these patients here. And therefore, their threshold may have been considered reduced because of other problems due to the TBI itself. But as you can see, patients who have intracranial pressure of 15 million years HG, very few have gone on to poor outcome.
stimulus intensity of 20 millimeters hg even though it's considered to be normal intracranial pressure if exposed uh maintained for a long period of time let's say 37 more than 37 minutes then even though the patient does have 20 millimeters hg the patients will have a negative outcome uh despite um the the value simply because the patient has been exposed to this threshold to this intensity for a long period of time And this actually reduces the time necessary for patients to go on towards a negative outcome with a 20 millimeter HG threshold. It's reduced even greater if the patients are presented by children, pediatric population. This has also been repeated in a study performed in Cambridge where they actually found negative outcomes already starting at 13 minutes exposure of 20 millimeters HG in TBI patients, retrospective study. And things get worse when the patients have disturbed cerebral autovascular regulation, as you can see here.
So another question is, okay, I see intracranial hypertension is correlated to bad outcome, but what if I monitor these patients? Is the monitoring itself correlated to a change in the outcome? Ever since the beginning of the 80s, where Narayan actually described that despite knowing that intracranial hypertension is correlated to bad outcome, the fact that whether we monitor or do not monitor these patients has not given us any proof whether monitoring does actually improve outcome or not. There is one study, it's the Synapsis ICP study, which has shown some benefit in patients who had at least one reactive pupil, some benefit of monitoring ICP. Patients who receive ICP monitoring went on to have a better outcome if they were stratified by pupil reactivity.
You probably all know this study, performed by Randy Chestnut in 2012, where he actually compared two groups using composite outcome. He compared low-middle-income countries in South America, where they used the ICE protocol. That means that patients who had a traumatic brain injury, they did not have invasive ICP monitoring, but their therapy was based on only imaging and their clinical examination. That's the ICE on the left. You would just have a consensus which was based on this ICE protocol. And basically, they indicate what we should look at on CT scans when we're trying to decide what type of a therapy to start and what type of strategy to start in these patients without having ICP monitoring. And this population was compared to high-income countries in Europe and the United States and other areas in the world where ICP monitoring was routinely applied. And guess what? No difference in outcome between these two groups.
I'm not that surprised by this result, actually, because Randy's findings were kind of an eye-opener, since the patient outcome cannot depend only on one single number, on whether the patient has a high intracranial hypertension or not. But we also have to know why that patient has increased ICP. Why is that number above a certain threshold? I compare it to fever in the ICU. We can measure the patient's temperature. If the patient has fever...
We could reduce the fever by using antibiotic drugs, but we need to try to find what the cause of the fever is. And if we treat all types of fever in the same way, we might risk doing harm to certain patients. We have to know if we have to use antibiotics or antiviral drugs or whatnot. So it's important not only to look at the symptom and treat the symptom itself, in this case, an increase in ICP, but we have to know what has caused it. As a matter of fact, in the Seattle consensus in 2019, they also indicate what types of treatments are not recommended when only a single ICP monitoring is used.
Just to use as an example, let's look at the problem with hypotension in patients who have had severe traumatic brain injury. Now, we know that hypotension, let's adjust this to age. Okay. Hypotension, along with hypoxia in TBI patients, especially in the early phase, is an independent... is independently correlated to poor outcome. And as you can see here, in this figure here, it kind of makes kind of a typical U-shaped curve where, especially if you go towards the left, towards hypotension, the patient's outcome will deteriorate. And therefore, the guidelines which have been made based on this fact indicate that patients who have TBI should maintain a systolic blood pressure above 100 or 110 millimeters HG and mean arterial pressure above 80 or 90 millimeters HG.
based on also the age and if there are any extracranial injuries involved. But we're kind of doing the same, and also, sorry, the sewer perfusion pressure is indicated to be, in the BTF guidelines, should be, the indicated sewer perfusion pressure should be maintained between 60 and 70 millimeters HG. So... This is kind of a one-size-fits-fit-all protocol. This protocol should give benefit to everybody who would be using this protocol who has had TBI. Actually, as we can see from this figure, this graph, the time course of CBF in following head injury is not always uniform. You can start from, especially during a few hours, where the CBF may be below threshold, and then during the course of the patients.
ICU stay or wherever the patient has been admitted to, that CBF may increase and then normalize the patient where to survive. This is another example. In white, in this trajectory, you had vasogenic edema. In red, you would have cerebral blood flow, and yellow is indicating cytotoxic edema. In the first phase of TBI, you would have a phase where the patient would be hypoperfused, and therefore you need to defend CPP, increase, try to increase your mean arterial blood pressure, because ICP will have increased mostly due to cytotoxic edema. So TBI is high.
cerebral edema is present, cerebral blood flow is low, so you need to push that driving pressure, and therefore CPP. The following days, many patients go towards having this autonomy. They would have maybe a loss in cerebral autoregulation, and they may start to become, they have a catecholaminergic surge, or similar episodes where you see the patients starting to have increase in arterial blood pressure, or here you could also have vasoplegia, and therefore hyperemia. And this may eventually lead to what we all know as vasogenic edema. And this also may cause an increase in intracranial pressure. So therefore, you have two different phases. One is characterized by a low CVF and the other is characterized by hyperemia. However, both have an increase in ICP. If you were to treat these patients blindly, maybe the first phase you treat this patient with a hypotensive drugs and this patient with a hypotensive drug, you will wind up doing harm to these patients.
So we, as mentioned previously, one size does not fit all. And since we're going towards a more tailor-made medicine and our strategies also have to be indicated in that sense. But we do need more information, don't we, in order to treat our patients. I mentioned before cerebral autoregulation. We know that cerebral autoregulation or blood flow within our brain is regulated.
towards where the brain mostly needs it. And it's done through mechanisms which are similar to traffic lights. These traffic lights are represented by four main mechanisms. And the one we'll be most interested in speaking about today is pressure autoregulation. Now, let's say ICPs maintain constant pressure autoregulation, is mainly varied and controlled by increases and reductions in resistance, fibroblastal resistance. And this is where all the action is, mainly where the small materials and precapular...
arterioles are contained. Therefore, by vasodilation, which causes a reduction in resistance, and vasoconstriction, which causes an increase in resistance, we can respectively increase or reduce cerebral blood flow. Without cerebral autoregulation, our cerebral blood vessels would be very similar to a normal pipe where any increase or reduction in the pressure within the pipe would cause an increase or reduction in the flow without any regulation. It was Blassen in Bethesda who firstly indicated this mechanism of cerebral autoregulation, creating the Blassen curve.
And just briefly, I think it would be worthwhile to speak about cerebrovascular regulation. We know that if you consider arterial blood pressure as our first parameter, if you would increase arterial blood pressure, that would cause, as I mentioned earlier, an increase in cerebrovascular resistance. This is due to a vascular constriction, and this would cause a reduction in the cerebral blood volume, obviously. And therefore, if you're measuring ICP, you will see a reduction in intracranial pressure. Therefore, you have here an increase in one parameter, a reduction in the second parameter, in this case ICP, and that's a negative correlation. Negative correlation indicates a conserved cerebrovascular order regulation. And this is what, if you're using a certain type of monetary system, this is called the PRX, and this is the pressure reactivity index. And just to provide you with a threshold, which I will get into later on, a normal threshold is a PRX below 0.2. So that's a negative correlation.
The same way if I were to reduce arterial blood pressure, that will cause vasodilation. In order to reduce the resistance, vasodilation within the cerebral blood vessels will lead to an increase in cerebral blood volume and therefore an increase in intracranial pressure. And here we still have a negative correlation. Therefore, the PRX is still 0.2, therefore indicative of preserved arterial vascular regulation. If, however, these two parameters, or we could even use other parameters, for example, flow velocity as measured by TCD or cerebral oxygenation as measured by invasive or non-invasive oxygenation methods, if these parameters move in the same direction, then the correlation is positive, and therefore we would have a disturbed cerebrovascular order regulation. In this case, PRX would indicate a threshold value of above 0.2.
And this is the Lassen, let's say, modern version of the Lassen curve, where between values of 50 and 150 millimeters Hg of cerebral perfusion pressure or arterial pressure, if you're not using, if you're not measuring ICP, our cerebral blood flow will be maintained constant. Below the valve threshold of 50, your vessels will start to eventually collapse until they go towards a critical closing pressure, and that will cause a complete subocirculatory arrest. Above 150 millimeters HG, eventually the subavascular autoregulation mechanisms will be exhausted, and therefore, instead of having a vasoconstriction, then your vessels will start to dilate and you will have hyperemia.
And this is just, again, represented in this figure here. If you maintain that negative correlation between these two values here, 50 and 150, the PRX would indicate a value below 0.2. Below or above these thresholds, you would have these parameters moving in the same direction, and therefore a positive correlation and disturbed fibrovascular odoregulation. We just had a meeting in Imola. It was kind of cool because we had all the race car boxes just to ourselves for the meeting. And in each box, we had workshops going on. And in one of the workshops, I spoke about auto-regulation. And obviously, since they gave each one of us a chance to have a run on the racetrack in one of these Formula One cars with two seats, the pilot was in the back, actually.
The guest was in the front. And I could assure you that at 300 kilometers, which is about 180, 190 miles per hour, the road would kind of look a tenth of what it actually was in the sense of diameter. It's obviously an optical illusion. But let's say that this road was actually in that way, made in that way, that we would have a large road here, the width would be kind of large, and we would have a very narrow part of the road here. I look at auto-regulation as being...
um having a safe area here where we would have a large threshold of 50 and 100 millimeters hg and if we were to move towards the left towards the right we would have to we have a large space within which we could we could drive our home-in-one car without going towards uh any problems and all the btf guidelines actually as mentioned previously indicate a safe area as being between 60 and 70 millimeters hg however in patients with brain injury in general this uh area is uh is actually narrowed the autoregulatory thresholds become narrower. Therefore, if we were to apply the indication of the BTF guidelines between 16 and 17, then we wouldn't have much room where we could actually drive our car without going towards any problems, without correction. It's just an example. And that's kind of what happens. We could actually have patients that would not have any autoregulatory mechanisms at all, and it would look like the first figure which I showed you, almost looking like a straight line, where we would have patients who would not autoregulate at all and have
what I showed previously, these parameters moving in the same direction where above this threshold, you would have an increase in ICP and below this threshold, you would have a reduction in ICP, but the price you would pay would be a reduction in cerebral blood flow. And if we were to have all our patients, this is where one size does not fit all. If we would have all our brain trauma patients or even stroke patients or whatnot to follow just one single protocol and have one single indication of threshold, in this case, the BTF and brain trauma in TBI patients, a threshold of 60 to 70. we would miss all those patients who would have disturbed ordoregulation and have that ordoregulatory curve move towards the right. Therefore, in these patients, they would go towards a hypoperfusion and therefore brain ischemia.
There are ways of measuring cerebral autoregulation. And we did acquire one of the softwares, that's the ICM Plus from Peter Smileski in Cambridge, which has become now, this is what it looked like at the beginning when we acquired it. And now they actually are quite, it's become quite modern. And many centers and states also have acquired the system. Actually gives you a good indication if the patient is autoregulating or not, both through these linear or these graphs and also a color graph. As you can see, when the...
these two parameters, CPP and ICP, move in the same direction, the red is shown here as a disturbed serial autoregulation. And when they move in the opposite direction, therefore autoregulation preserved, the code of code turns green. I should move on. And it's also possible to find, if you plot this on a chart, putting the CPP on the bottom and the PRX on the left, we could find the best CPP. And that's the superfusion pressure, where the brain is mostly protected, since that's the area where CBA, supervascular regulation, is mostly preserved. So how do we perform diagnosis of intracran hypertension? Obviously by...
We could measure intracranial pressure, but we could also look at CT scans, maybe. A CT scan is effective when we're looking at indicators of intracranial hypertension, for example, brain swelling or compressed cisterns or a midline shift or a reduction in the gray and white differentiation and whatnot. But we may miss lesions, for example, of the brainstem or a diffuse axonal injury, which are not actually correlated necessarily with increases in ICP, but they are correlated with a negative or a poor outcome. In this case, MRI is much more accurate in picking up these lesions, and they can give us maybe an indication of who are the patients that would benefit from therapies which are directed towards a reduction in ICP. Avoiding these types of therapies, which sometimes can be harmful, avoiding these types of therapies in patients who would not benefit from ICP therapies.
So therefore, we have to, we must distinguish between two groups of patients, intracranial hypertension, which represents the cause of poor outcome, and intracranial hypertension, which simply represents a marker of a poor outcome. There was this interesting study performed in Lancet in 2019, this is the Center TPI group, where they performed a series of MRI and CT scans, and they seen that roughly 8% of patients had a positive CT with a negative MRI, so the CT in these 8% was a bit more... accurate in picking up post-traumatic SAH or an epidural hematoma. Maybe this may be due to timing. However, there were 16% of patients who had a positive MRI despite having a negative MRI. And detecting a negative CT with a positive MRI lesions could actually identify those patients less likely to benefit from aggressive ICP therapy, which I mentioned previously. We may use biomarkers in order to try to get an indication of whether the patient may have certain types of injuries or not.
It looks promising, but we're not actually there yet. So we need to measure the ICP itself. And there are both invasive and non-invasive methods of measuring ICP. These methods ideally should be easily equipped to apply. They should be reliable. They should not be associated with complications, and they should be bedside. Regarding the invasive methods for measuring ICP, they do represent the gold standard.
And these are just some of the devices out on the field, which you are very familiar with. The gold standard is represented by an intraventricular catheter inserted through a bolt or maybe even tunneled through the scalp into one of the ventricles, article ventricles. And this is obviously an invasive method, which is highly reliable. However, not easy to apply or quick to apply. It is associated with complications, for example.
especially infections. And at least in my center, we don't normally perform it bedside. It is performed in the OR. The intravenical catheter can give us a lot of information. We measure ICP for two reasons. One, to have information regarding intracranial hypertension. Two, to have information regarding cerebral perfusion pressure. Because as I mentioned previously, and as indicated here, CPP is the difference between minotaur pressure and ICP.
And also for therapeutic reasons, obviously, because if we introduce a catheter within the ventricles, we could use this device to drain CSF in case of increased intracranial pressure. And we could also set the limit based on how much we want to drain on a certain threshold here indicated as 10 millimeters HG. And we also... Here we can look at some certain types of waveforms. Here you have information just by looking at the waveform, whether the intracranial pressure is increased or not, by comparing these three indicators here, P1, P2, P3, which are respectively related to the arterial pulse and to the rebound pulse, which is the cerebral compliance, and also the third, which is the necrotic notch in the arterial pulse. If P2 should surpass P1, then this is an indicator of increased intracranial pressure.
hypertension. And if they would actually disappear, this means that the hypertension is actually quite high. Remember, once we insert this ventricular train, we reduce the intracranial pressure, but we're just buying time. We have to still verify what has actually increased the intracranial pressure itself. It's almost like decompressive craniectomy. Once you perform decompressive craniectomy, the problem hasn't resolved. You just resolve it temporarily. You still have to find out and treat what has caused that increase in intracranial pressure, which has brought you to that decompressive craniectomy itself.
And remember that once you insert the drain, you have to be careful. If there is not a communication between the ventricles or the CSF, then you may cause a problem. If you completely drain on one side, this can cause a shift. It could cause it down to P towards the ventricle, which has been drained. And also if you have overdrainage of the, these are actually two catheters inserted. If you have overdrainage, then you will go towards what they call a slip ventricles. And this may be correlated also with the contents of the client. Another form of invasive ICP monitoring is a boat screw, which is completely inserted.
which is inserted through the scalp into the subarachnoid space and here you would insert a catheter into the um into the brain for recommend just a few millimeters and it's relatively easy to apply it is reliable and it's performed at bedside and i will just spend just a couple of minutes on this topic itself we uh can we What I mean by is can we save time? I don't know what you do there in Baltimore where you're listening from. We performed a few studies. One of our colleagues spent some time at Richmond in Virginia where Anthony Marmaru used to work. And when he came back, we started putting in placing bolts ourselves actually since the late 1980s. So together with other studies, there's a lot of literature showing that ICP bolts can be placed by intensive care physicians without any differences in the complication rate.
And I'm performing a study now where it's called Timing ICP, and that's the acronym right here. It's in Italy. It's a multi-center study in Italy where I'm comparing the ICP boat placement, the time necessary to place the boat between intensive care physicians and neurosurgeons. And what I'm looking at here is not who does it better, obviously, but how much time it takes for how much time do we actually save if an intensive care physician, after consultation, obviously, with a neurosurgeon, that's always necessary, puts in both him or herself. compared to the involvement of the neurosurgeon also through maybe having to find the surgeons. Neurosurgeons have a lot of things to do. So maybe sometimes as for any consultation, it may take some time for the other second physician to be involved. So we're looking at, we're comparing it between these two categories. And we're looking at the time difference between indication of ICP monitoring itself and the time that passes between indication and the actual skin incision between, again, between two categories. The incision performed by the intensivist.
or by the neurosurgeon. And the idea, again, is that the more time you spend without ICP monitoring, as we've seen previously when we spoke about the dose, if it's true that the more time you spend with high ICP, the worse of the outcome, then it's true that the more time you spend without treating high ICP, Theoretically, you would have a worse outcome. Outcome is a different story. I hope to look at that in a different study. But we're trying to reduce the time spent without any ICP monitoring. And that hopefully would mean that the patient would be monitored earlier. And as Paul Vespa in UCLA would frequently say, to detect is to protect. And just to give you a hint, this is just a training that we performed. We performed the interim analysis. And we've seen that until now, the median time that we actually save goes from 45 to an hour and a half.
So time is actually saved by performing it ourselves. Non-invasive methods, very briefly, they are very easily and quick to apply and no complication rate, obviously, because they're non-invasive and many are performed at bedside. But regarding reliability, it's a different story, isn't it? I'll speak about TCD and optic node sheet diameter very briefly. I've worked a few years in Cambridge where I picked up this method. This is a formula which was initially created by Rune Asli, who actually was the first to perform Doppler.
trans-cranially in Austria, modified by the Cambridge group, by Amarik Sosnikov, just by inserting diastolic flow velocity within the formula. And he actually was able to estimate CPP non-invasively with a roughly good average. 86% of the measurements fell within a range of 10 mmHg of the true CPP measured invasively. And obviously, if you, again, with that formula, subtract CPP from mean arterial pressure, you would get non-invasive ICP. I performed a first study, a pilot study.
in Italy, where I've seen, I compared non-invasive measurement to the gold standard, any type of invasive method. And I performed three correlations, TCD before the ICP insertion, and then the first measurement of ICP measured invasively. A second measurement, correlation between TCD measured ICP and invasive measurement right after invasive ICP insertion. And the third correlation performed two to three hours after the ICP measurement, invasive ICP measurement. And we actually found quite astonishing results. If we use the threshold of
20 millimeters HG, then 18 out of the 21 readings, the TCD showed an accurate reading compared to invasive ICP measurement. If that threshold was increased to 24.8 millimeters HG, then the accuracy actually increased quite like, sensitivity actually increased almost to 100%, meaning that the ICP measured non-invasively through TCD actually excluded true intracranial hypertension almost 100% of the time. However, it kind of... overestimated ICP quite oftenly.
We investigated this further through a multicenter international study looking at four main intracranial pathologies, TBISAH, intracranial hemorrhage, and ischemic stroke. And 16 centers were involved, including a center in the States, which was the Columbia, New York. We included 262 patients, 687 paired measurements of non-invasive and invasive ICP measurements were performed at three different thresholds of 20, 20, 25 millimeters HG. Let's say that there was the error range when we're looking at the Blunt and Ottman thresholds. There was quite a lot of error. But what, again, we were able to confirm is that there was a very high negative predictive value of transcranial Doppler in measuring non-invasive ICP, which was quite high. It increased, obviously, going from 20 to 25. But this meant, again, that the non-invasive TCD method was very accurate in excluding the presence of intracranial hypertension. However, there was a quite high overshoot.
meaning that when TCD showed that ICP was high, it wasn't necessarily high on invasive measurement. But we're looking at a second study. where we're trying to see if maybe a TCD, when it indicated a high value of ICP, maybe it was telling us, giving us further information, maybe indicating altered resistance. We're also looking into performing a third study. This would be a randomized control trial where it would be randomizing based on the uncertainty principles. We exclude patients who would definitely require ICP and patients who would definitely not require invasive ICP. And those who would have a uncertain indication of ICP monitoring, we randomize these patients to either receiving invasive ICP monitoring.
or non-invasive ICP monitoring. We're still at the bench process of this study and we're doing the statistics for this. Another method I'm sure you're all familiar with is the optic nerve sheath diameter measurement. Very quickly, we know that the optic nerve is in communication with the brain subarachnoid area space through the subarachnoid fluid, which circumnavigates the optic nerve. And when there's an increase in intracranial pressure, this would dilate, this would increase the space between the optic nerve sheath, and therefore it would surpass a certain threshold, which we consider to be five millimeters.
And where would we measure this? That way we would just simply look at, find the retina with the ultrasound, move three millimeters posterior towards the optic nerve from the retina. And at this point, we would measure the diameter between the optic nerve sheet. If this diameter would be above, again, 0.5 centimeters or five millimeters, in this case, it's almost six. And this would be indicative of intracranial hypertension. If it's below that threshold, this patient most likely would not have intracranial hypertension. Again, this is a threshold. One size does not fit all. And this is also equivalent to.
patient's nerve sheath diameter. But let's say if you have very high values of optic nerve sheath diameter or very low values, then this would most likely indicate or not indicate intracranial hypertension, especially if you use this method with other non-invasive methods. In this study, we've performed a systematic review led by Kararova, where we've seen that in the systematic review and meta-analysis, that optic nerve sheath diameter compared to other methods of measuring ICP noninvasively did have a higher specificity compared to the other methods. Upcoming automated pupilometry, which is being used in many areas, also regarding intrapreneur hypertension, by using, it's been known for quite some time now, that a reduction in the constriction velocity and in the pupillary light reflex and in asymmetry in the pupils, is correlated with an increase in intracranial pressure. And a lot of work done by Mauro Odo and his group and Fabio Tacona, we've also performed some studies where we've shown that an index derived from this pupilometer, in particular from neuroptics, when it is altered, this corresponds and correlates quite well to an increase in intracranial pressure. And when treating the intracranial pressure, let's say with osmotic therapy, the index will return to normal values. And this is highly correlated to outcome, so upcoming.
Actually, I've actually used it as they've used it in this study where they use the pupillometry to test whether closing and clamping an EVD drain, when one is trying to wean the patient from the EVD drain, if there is an altered NPI or a trend in altered NPI, this would actually indicate that there's an increase in intracranial hypertension. This correlates quite well to a CT scan indicating hydrocephalus. Again, it's very important to look at the waveforms. As mentioned previously, when you have a variation in the waveform, in this case, as mentioned before, variations in the P1 and the P2 waveforms, then this is indicative of a change or variation in compliance. There are other upcoming methods of measuring ICP non-invasively. This method in particular, the Rho-anarchicography, which was initially created in order to measure cerebral blood flow, now they're using the same concept, comparing the two peaks of P1 and P2.
They're looking into using this method to measure ICP normal. a waveform abnormal waveform just like as in the csf waveforms and this is another method which is actually you can look you can find this also on the internet where they use the same basically the same principle and it's done non-invasively it's just a crown placed around the circumference of the uh of your head and it measures the thermometry of the uh of the uh and the compliance of the brain scalp and measures their very subtle differences and it's actually picked up by this machine um very interesting to see that in this comparison you have here a patient who has the P2 higher than the P1, lumbar drainage is performed, and the P1 becomes higher than the P2, so a clear indication that the compliance was picked up by this machine and returned back to normal. There's actually a paper that's just been published regarding this concept. We also use, and having using a few papers published regarding this, a certain type of non-invasive ICP bundle, where once the patient comes into the emergency room, besides performing, when you're performing your FAST or your FOCUS, just take that same...
probe, and place it on the patient's head, and you could derive a lot of information from this exam. Looking at the brain, the optic nerve sheet diameter, you could actually look inside the brain and see if there's a midline shift or if there's a hematoma, and again, you could actually measure intracranial pressure. I'm not saying this would substitute the CT scan, and you should not delay CT scan, but while others are performing the first and second evaluation, this could be easily performed, and you could already have some important information before the patient goes to either operating room because there's a positive, fast examination, or to a CT scan, and there you could prep the a neuro operating room, neuro theater before the patient arrives. And if you want to look at it, it's been published into intensive care medicine in 2019, a very nice picture depicting all this, what I've just spoken about.
I'll go through this quite quickly. This is just an example of how we could use non-invasive ICP monitoring when invasive ICP monitoring is not possible. We could use it either together, an adjunct to invasive ICP monitoring, or when it's not possible because a patient may be awake or may have an appointment of cardiopathy, or when we may not have the possibility of having a neurosurgeon on hand, we could initially perform non-invasive ICP monitoring followed by imaging. Very quickly, I'm going towards the end. Management, we know that monitor is only worthwhile if it's able to change or make you make, sorry.
influence your therapeutic strategy. Otherwise, it's not useful at all. However, we know that the mechanisms leading to secondary brain damage are quite, or many, and our therapies until now, which have been aimed at treating or avoiding secondary brain injury, haven't been quite successful. And that's kind of easy to understand since, again, the paths that lead towards secondary brain injury are quite a lot. You can't just block one mechanism and expect the other mechanisms to not.
continue their path. I compare it almost like to the Milano underground, the subway, that if I were to go from point A to point B, representing secondary brain damage, if you want to block my path, you won't be able to do it by just blocking one singular path. You need to block all the other ways I could manage going from point A to point B, and eventually I could still reach it. In Brescia, where I live, actually, it would be nice if we would have an air mechanism which was actually similar to the Brescia underground. You only have a north and a south, so if you would block my path in this area, you would block a brain injury, but it's not that way. There's no magic bullet.
We could get some help from multimodality monitoring. Just an example, if we just have one single monitoring method, we won't know for certain if the parameter is going in the right direction. If we have other monitoring methods, this could kind of give us a better indication. It may be that one single monitor is telling us something different compared to everybody else who's going in a different direction. There are both invasive methods. This is just one patient. This is an old slide of one of our patients 10 years ago. We had both invasive methods and non-invasive methods. If I were to, however, pick between the necessary invasive and non-invasive methods.
These are the ones which I would definitely not do without. Invasive intracranial pressure is still a gold standard, as is brain tissue oxygenation and autoregulation. And then pupillometry, ultrasound, continuous CG and imaging could definitely give us more information to help treat outpatient 360 degrees. I'm finishing with these two slides. This is the, if we want to treat intracranial pressure, let's say due to traumatic brain injury, there are a lot of flow charts which have been created. This is the flow chart created after the Seattle International TBI consensus conference, where you would start from tier zero, where there are the basic general principles that you would use in order to maintain a certain steady state in any patient, besides whether it be TBI patient or any type of patient.
And TBI patient in particular, you would maintain hemoglobin above seven, an elevated head maybe above 30 degrees and below 45 degrees in order to favor CSF flow. And sedation should be performed but not too deep and also try to maintain a normal CO2. And obviously, the patient has to be mechanically ventilated since we're speaking about severe TBI. If the patient would have an increase in intracranial pressure, then you would increase to first, second, and third tier therapies, not necessarily in disorder. You would also go from a...
a tier one directly to a tier two therapy based on the necessity to treat intracranial hypertension and its severity. And I won't get into this in the specifics, but you would go from a tier one where you would need to maybe consider hypertonic saline or if it's not placed in a certain EBD drain to a tier two where you might have to hyperventilate briefly without performing prophylactic hyperventilation that would cause initially a vasoconstriction and therefore... reduction in CVF. And if this is not enough, you may have to resort to going towards tier three therapies, which is barbitricoma or decompressive craniectomy or even hypothermia. Must bear in mind, this is very important, that as you move towards a more aggressive therapy, the side effects will increase. However, the evidence-based medicine regarding these therapies will move in a different direction. For example, the BEST-TRIP trial, which is the Randy Chesner trial, along with the DECRA, the early decompression craniectomy and the two hypothermia trials haven't actually shown.
a definite benefit regarding the outcome of these patients. Very quickly, there are do's and don'ts of treating intracranial hypertension. Whatever we do as a do will be followed by a don't. Be very careful, as mentioned previously, not to over hyperventilate the patient because of vasoconstriction. Also, any type of therapy that we can perform, if not done correctly, may have a negative effect on the patient.
Finishing with this slide, this is a very nice slide made by Gerd Mayfreud, a slide paper published by Gerd Mayfreud, where he basically used information derived from the BOOST 2 study and the BOOST 3 studies actually on the other hand, where using information derived from ICP and brain tissue oxygenation, based on the fact that if one or both are altered, to distinct the different tier therapies on the oxygenation or the intracranial pressure. and the combination of both these parameters. Actually, I'm definitely sure my time is up, so I would like to thank you for your attention if I've left anybody awake during all this. Thank you very much.
Thank you so much, Dr. Tullo. I know some of the fellows probably had to hop off to go back to some clinical duties. I don't see anything in the chat, but I'm happy, would be happy if someone had a question. They can just unmute themselves or type it in the chat. And I guess I'll just start off with my one question. And it's mostly about non-invasive neuromonitoring. And do you foresee this, you know, like a POCUS brain ultrasound is becoming part of training for critical care fellows? For me, I'm interested really about the fellows.
you know, not in the neurocritical care unit, thinking about patients with fulminant hepatic failure, how much they would benefit from non-invasive monitoring. And so do you see that becoming a part of our training, like we think of focus for the physical exam otherwise? I think the information derived from ultrasound in general is not only useful, but it's fundamental. Because as I mentioned during the talk, that even if you have invasive monitoring, again, I do put invasive monitoring myself, so I think it's the gold standard, the looking at what's going on within the brain. is very important. You can distinguish between just by using ultrasound and hyperemia or hypoperfusion. That's if you don't have brain oxygenation, which can tell you, give you the same information. But combining these types of methods, invasive method with a non-invasive method, can be very important. It can be fundamental into treating, into variating your therapeutic strategy. For example, you mentioned acute hepatic failure. I know there are centers even in the States where they would use invasive ICP monitoring at a certain stage for these patients to decide whether they would go on to having
towards having a transplant or not. It's, you know, these patients very frequently have problems with their coagulation. So when you put in invasive monitoring, it is associated with a high complication rate. I was looking into trying to form a study where we would substitute, not substitute, but compare non-invasive monitoring to invasive monitoring in these patients. But let's say the sample size wasn't high enough to perform it. So therefore, that kind of led me to perform the impressive ICP study where we compared them. It is DCD measurement of non-invasive ICP is being used.
to select these patients, however, in certain centers. But it should be part of the training. Just to answer your question, it definitely should be part of training. I think that's it for the questions. We really appreciate you taking the time to chat with us. It was, like I said, our home group was thrilled to have you here. So we thank you so much. Long time. A lot of slack. No, that's okay. It was great. Thank you again. Thank you. Bye-bye. Bye-bye. Thank you.